Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001567619-20-018000

President acquired 273,057 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Beigelman Leonid President 2020-10-20 Conversion +163,842 163,842 I
Beigelman Leonid President 2020-10-20 Conversion +13,559 13,559 I
Beigelman Leonid President 2020-10-20 Conversion +13,559 13,559 I
Beigelman Leonid President 2020-10-20 Conversion +50,781 214,623 I
Beigelman Leonid President 2020-10-20 Conversion +3,359 16,918 I
Beigelman Leonid President 2020-10-20 Conversion +3,359 16,918 I
Beigelman Leonid President 2020-10-20 Conversion +21,724 236,347 I
Beigelman Leonid President 2020-10-20 Conversion +1,437 18,355 I
Beigelman Leonid President 2020-10-20 Conversion +1,437 18,355 I
Derivatives
Beigelman Leonid President 2020-10-20 Conversion · Series A Preferred Stock −163,842 0 I
Beigelman Leonid President 2020-10-20 Conversion · Series A Preferred Stock −13,559 0 I
Beigelman Leonid President 2020-10-20 Conversion · Series A Preferred Stock −13,559 0 I
Beigelman Leonid President 2020-10-20 Conversion · Series B-1 Preferred Stock −50,781 0 I
Beigelman Leonid President 2020-10-20 Conversion · Series B-1 Preferred Stock −3,359 0 I
Beigelman Leonid President 2020-10-20 Conversion · Series B-1 Preferred Stock −3,359 0 I
Beigelman Leonid President 2020-10-20 Conversion · Series B-2 Preferred Stock −21,724 0 I
Beigelman Leonid President 2020-10-20 Conversion · Series B-2 Preferred Stock −1,437 0 I
Beigelman Leonid President 2020-10-20 Conversion · Series B-2 Preferred Stock −1,437 0 I
Loading xslF345X03/doc1.xml…